Fennec Pharmaceuticals Inc

NASDAQ:FENC  
6.72
-0.16 (-2.33%)
Products

Fennec Pharmaceuticals Resubmits New Drug Application To U.S. FDA For Pedmark™

Published: 05/28/2021 10:06 GMT
Fennec Pharmaceuticals Inc (FENC) - Fennec Pharmaceuticals Resubmits New Drug Application to U.S. Food and Drug Administration for Pedmark™.